PHARMADVICE ApS: Financial statements 2012
CVR: 26527651
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 3,411,184 and a net result of DKK -1,285. Equity in the 2012 report amounted to DKK 1,182,200. The solvency ratio was 52.8%.
- Gross Profit
- DKK 3,411,184
- Profit/Loss
- DKK -1,285
- Equity
- DKK 1,182,200
- Total Assets
- DKK 2,238,918
Official annual report
Keep an eye on PHARMADVICE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of November 23, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMADVICE ApS.
As of November 23, 2012, MJAKP2 I/S has stepped down as auditor of PHARMADVICE ApS.
About PHARMADVICE ApS
PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.